Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Peter Lawson is an analyst at Barclays. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/28/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/07/2025 | TCRX | Buy Now | TScan Therapeutics | $1.45 | 106.9% | Peter Lawson42% | $14 → $3 | Maintains | Overweight | Get Alert |
| 02/27/2025 | GERN | Buy Now | Geron | $1.65 | 142.39% | Peter Lawson42% | $9 → $4 | Maintains | Overweight | Get Alert |
| 02/13/2025 | EXEL | Buy Now | Exelixis | $36.71 | -21% | Peter Lawson42% | $25 → $29 | Maintains | Equal-Weight | Get Alert |
| 02/03/2025 | ARVN | Buy Now | Arvinas | $8.10 | 295.06% | Peter Lawson42% | $48 → $32 | Maintains | Overweight | Get Alert |
| 10/30/2024 | BMEA | Buy Now | Biomea Fusion | $2.51 | 338.44% | Peter Lawson42% | $9 → $11 | Maintains | Equal-Weight | Get Alert |
| 10/25/2024 | RCUS | Buy Now | Arcus Biosciences | $8.57 | 238.39% | Peter Lawson42% | $25 → $29 | Maintains | Overweight | Get Alert |
| 09/27/2024 | RVMD | Buy Now | Revolution Medicines | $37.98 | 57.98% | Peter Lawson42% | $54 → $60 | Maintains | Overweight | Get Alert |
| 09/27/2024 | BMEA | Buy Now | Biomea Fusion | $2.51 | 258.72% | Peter Lawson42% | $5 → $9 | Maintains | Equal-Weight | Get Alert |
| 09/10/2024 | RLAY | Buy Now | Relay Therapeutics | $2.98 | 470.47% | Peter Lawson42% | $14 → $17 | Maintains | Overweight | Get Alert |
| 08/15/2024 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.75 | 140% | Peter Lawson42% | $32 → $33 | Maintains | Overweight | Get Alert |
| 08/13/2024 | EXAI | Buy Now | Exscientia | — | — | Peter Lawson42% | → $5 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/09/2024 | IMCR | Buy Now | Immunocore Hldgs | $30.13 | 119.05% | Peter Lawson42% | $92 → $66 | Maintains | Overweight | Get Alert |
| 07/31/2024 | MGNX | Buy Now | Macrogenics | $1.50 | 433.33% | Peter Lawson42% | $9 → $8 | Maintains | Overweight | Get Alert |
| 07/31/2024 | ARVN | Buy Now | Arvinas | $8.10 | 492.59% | Peter Lawson42% | $60 → $48 | Maintains | Overweight | Get Alert |
| 07/29/2024 | BPMC | Buy Now | Blueprint Medicines | $89.60 | 17.19% | Peter Lawson42% | $75 → $105 | Maintains | Equal-Weight | Get Alert |
| 07/29/2024 | MGNX | Buy Now | Macrogenics | $1.50 | 500% | Peter Lawson42% | $14 → $9 | Maintains | Overweight | Get Alert |
| 07/29/2024 | EXAI | Buy Now | Exscientia | — | — | Peter Lawson42% | $10 → $9 | Maintains | Overweight | Get Alert |
| 07/26/2024 | RLAY | Buy Now | Relay Therapeutics | $2.98 | 369.8% | Peter Lawson42% | $15 → $14 | Maintains | Overweight | Get Alert |
| 07/18/2024 | RVMD | Buy Now | Revolution Medicines | $37.98 | 42.18% | Peter Lawson42% | $52 → $54 | Maintains | Overweight | Get Alert |
| 07/15/2024 | NRIX | Buy Now | Nurix Therapeutics | $12.55 | 147.01% | Peter Lawson42% | $20 → $31 | Maintains | Overweight | Get Alert |
| 07/12/2024 | RVMD | Buy Now | Revolution Medicines | $37.98 | 36.91% | Peter Lawson42% | → $52 | Initiates | → Overweight | Get Alert |
| 07/08/2024 | RCUS | Buy Now | Arcus Biosciences | $8.57 | 191.72% | Peter Lawson42% | $35 → $25 | Maintains | Overweight | Get Alert |
| 06/07/2024 | REPL | Buy Now | Replimune Group | $10.45 | 62.68% | Peter Lawson42% | $13 → $17 | Maintains | Overweight | Get Alert |
| 06/07/2024 | BMEA | Buy Now | Biomea Fusion | $2.51 | 99.29% | Peter Lawson42% | $30 → $5 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/24/2024 | TNGX | Buy Now | Tango Therapeutics | $1.66 | 683.13% | Peter Lawson42% | $18 → $13 | Maintains | Overweight | Get Alert |
| 05/10/2024 | MGNX | Buy Now | Macrogenics | $1.50 | 833.33% | Peter Lawson42% | $25 → $14 | Maintains | Overweight | Get Alert |
| 05/10/2024 | RLAY | Buy Now | Relay Therapeutics | $2.98 | 403.36% | Peter Lawson42% | $15 → $15 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 05/03/2024 | BPMC | Buy Now | Blueprint Medicines | $89.60 | -16.29% | Peter Lawson42% | $70 → $75 | Maintains | Equal-Weight | Get Alert |
| 04/30/2024 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Peter Lawson42% | $9 → $26 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 04/11/2024 | EXEL | Buy Now | Exelixis | $36.71 | -31.9% | Peter Lawson42% | $25 → $25 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 03/08/2024 | MGNX | Buy Now | Macrogenics | $1.50 | 1566.67% | Peter Lawson42% | $23 → $25 | Maintains | Overweight | Get Alert |
| 03/07/2024 | TCRX | Buy Now | TScan Therapeutics | $1.45 | 520.69% | Peter Lawson42% | $7 → $9 | Maintains | Overweight | Get Alert |
| 02/29/2024 | ARVN | Buy Now | Arvinas | $8.10 | 640.74% | Peter Lawson42% | $26 → $60 | Maintains | Overweight | Get Alert |
| 02/29/2024 | IOVA | Buy Now | Iovance Biotherapeutics | $3.61 | 509.42% | Peter Lawson42% | $18 → $22 | Maintains | Overweight | Get Alert |
| 02/29/2024 | MGNX | Buy Now | Macrogenics | $1.50 | 1433.33% | Peter Lawson42% | $12 → $23 | Maintains | Overweight | Get Alert |
| 02/29/2024 | SWTX | Buy Now | SpringWorks Therapeutics | $46.70 | 34.9% | Peter Lawson42% | $47 → $63 | Maintains | Overweight | Get Alert |
| 02/27/2024 | FATE | Buy Now | Fate Therapeutics | $0.88 | 1039.86% | Peter Lawson42% | $6 → $10 | Maintains | Overweight | Get Alert |
| 02/13/2024 | BPMC | Buy Now | Blueprint Medicines | $89.60 | -21.87% | Peter Lawson42% | $58 → $70 | Maintains | Equal-Weight | Get Alert |
| 01/30/2024 | EXEL | Buy Now | Exelixis | $36.71 | -31.9% | Peter Lawson42% | $24 → $25 | Maintains | Overweight | Get Alert |
| 01/25/2024 | SWTX | Buy Now | SpringWorks Therapeutics | $46.70 | 0.64% | Peter Lawson42% | $41 → $47 | Maintains | Overweight | Get Alert |
| 12/06/2023 | REPL | Buy Now | Replimune Group | $10.45 | 24.4% | Peter Lawson42% | $50 → $13 | Maintains | Overweight | Get Alert |
| 12/04/2023 | IMGN | Buy Now | Immunogen | — | — | Peter Lawson42% | $27 → $31 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/01/2023 | IMGN | Buy Now | Immunogen | — | — | Peter Lawson42% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/27/2023 | BPMC | Buy Now | Blueprint Medicines | $89.60 | -35.27% | Peter Lawson42% | $46 → $58 | Maintains | Equal-Weight | Get Alert |
| 10/24/2023 | ARVN | Buy Now | Arvinas | $8.10 | 220.99% | Peter Lawson42% | $39 → $26 | Maintains | Overweight | Get Alert |
| 10/17/2023 | EXAI | Buy Now | Exscientia | — | — | Peter Lawson42% | $12 → $10 | Maintains | Overweight | Get Alert |
| 09/18/2023 | IOVA | Buy Now | Iovance Biotherapeutics | $3.61 | 398.61% | Peter Lawson42% | $40 → $18 | Maintains | Overweight | Get Alert |
| 08/10/2023 | FATE | Buy Now | Fate Therapeutics | $0.88 | 583.92% | Peter Lawson42% | $12 → $6 | Maintains | Overweight | Get Alert |
| 08/10/2023 | ADAP | Buy Now | Adaptimmune Therapeutics | $0.23 | 332.15% | Peter Lawson42% | $2 → $1 | Maintains | Underweight | Get Alert |
| 08/09/2023 | ARVN | Buy Now | Arvinas | $8.10 | 381.48% | Peter Lawson42% | $70 → $39 | Maintains | Overweight | Get Alert |
| 08/04/2023 | PRLD | Buy Now | Prelude Therapeutics | $0.74 | 575.68% | Peter Lawson42% | $7 → $5 | Maintains | Equal-Weight | Get Alert |
| 08/03/2023 | EXEL | Buy Now | Exelixis | $36.71 | -34.62% | Peter Lawson42% | $25 → $24 | Maintains | Overweight | Get Alert |
| 08/02/2023 | IMGN | Buy Now | Immunogen | — | — | Peter Lawson42% | $20 → $27 | Maintains | Overweight | Get Alert |
| 07/26/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.75 | 147.27% | Peter Lawson42% | $31 → $34 | Maintains | Overweight | Get Alert |
| 06/12/2023 | IMGN | Buy Now | Immunogen | — | — | Peter Lawson42% | $9 → $20 | Maintains | Overweight | Get Alert |
| 05/23/2023 | BPMC | Buy Now | Blueprint Medicines | $89.60 | -48.66% | Peter Lawson42% | $44 → $46 | Maintains | Equal-Weight | Get Alert |
| 05/12/2023 | BMEA | Buy Now | Biomea Fusion | $2.51 | 1892.91% | Peter Lawson42% | → $50 | Initiates | → Overweight | Get Alert |
| 04/28/2023 | SWTX | Buy Now | SpringWorks Therapeutics | $46.70 | -12.21% | Peter Lawson42% | $55 → $41 | Maintains | Overweight | Get Alert |
| 04/19/2023 | RLAY | Buy Now | Relay Therapeutics | $2.98 | 403.36% | Peter Lawson42% | $23 → $15 | Maintains | Equal-Weight | Get Alert |
| 03/09/2023 | NRIX | Buy Now | Nurix Therapeutics | $12.55 | 59.36% | Peter Lawson42% | → $20 | Initiates | → Overweight | Get Alert |
| 01/23/2023 | BPMC | Buy Now | Blueprint Medicines | $89.60 | -50.89% | Peter Lawson42% | $50 → $44 | Maintains | Equal-Weight | Get Alert |
| 01/04/2023 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Peter Lawson42% | $8 → $9 | Maintains | Underweight | Get Alert |
| 12/21/2022 | RCUS | Buy Now | Arcus Biosciences | $8.57 | 308.4% | Peter Lawson42% | $60 → $35 | Maintains | Overweight | Get Alert |
| 12/12/2022 | BPMC | Buy Now | Blueprint Medicines | $89.60 | -40.85% | Peter Lawson42% | $58 → $53 | Maintains | Equal-Weight | Get Alert |
| 11/30/2022 | IMCR | Buy Now | Immunocore Hldgs | $30.13 | 165.52% | Peter Lawson42% | → $80 | Initiates | → Overweight | Get Alert |
| 11/23/2022 | ARVN | Buy Now | Arvinas | $8.10 | 764.2% | Peter Lawson42% | $90 → $70 | Maintains | Overweight | Get Alert |
| 11/16/2022 | EXAI | Buy Now | Exscientia | — | — | Peter Lawson42% | $40 → $12 | Maintains | Overweight | Get Alert |
| 11/15/2022 | IMGN | Buy Now | Immunogen | — | — | Peter Lawson42% | $8 → $9 | Maintains | Overweight | Get Alert |
| 11/02/2022 | BPMC | Buy Now | Blueprint Medicines | $89.60 | -35.27% | Peter Lawson42% | $70 → $58 | Maintains | Equal-Weight | Get Alert |
| 09/30/2022 | RLAY | Buy Now | Relay Therapeutics | $2.98 | 671.81% | Peter Lawson42% | → $23 | Initiates | → Equal-Weight | Get Alert |
| 09/09/2022 | IMGN | Buy Now | Immunogen | — | — | Peter Lawson42% | → $8 | Initiates | → Overweight | Get Alert |
| 09/09/2022 | ARVN | Buy Now | Arvinas | $8.10 | 1011.11% | Peter Lawson42% | → $90 | Initiates | → Overweight | Get Alert |
| 08/16/2022 | NEXI | Buy Now | NexImmune | $0.00 | 1999900% | Peter Lawson42% | $175 → $50 | Maintains | Overweight | Get Alert |
| 08/09/2022 | MGNX | Buy Now | Macrogenics | $1.50 | 433.33% | Peter Lawson42% | $18 → $8 | Maintains | Overweight | Get Alert |
| 08/05/2022 | KPTI | Buy Now | Karyopharm Therapeutics | $4.40 | 81.82% | Peter Lawson42% | $210 → $120 | Maintains | Overweight | Get Alert |
| 07/28/2022 | BCYC | Buy Now | Bicycle Therapeutics | $9.26 | 223.97% | Peter Lawson42% | → $30 | Initiates | → Overweight | Get Alert |
| 07/07/2022 | CTMX | Buy Now | CytomX Therapeutics | $0.60 | 488.14% | Peter Lawson42% | $7 → $3.5 | Maintains | Overweight | Get Alert |
| 04/01/2022 | NEXI | Buy Now | NexImmune | $0.00 | 6999900% | Peter Lawson42% | $100 → $175 | Maintains | Overweight | Get Alert |
| 02/28/2022 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Peter Lawson42% | $11 → $6 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 02/28/2022 | PRLD | Buy Now | Prelude Therapeutics | $0.74 | 1521.62% | Peter Lawson42% | $20 → $12 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/18/2022 | CTMX | Buy Now | CytomX Therapeutics | $0.60 | 1076.27% | Peter Lawson42% | → $7 | Upgrade | Underweight → Overweight | Get Alert |
| 11/19/2021 | RCUS | Buy Now | Arcus Biosciences | $8.57 | 600.12% | Peter Lawson42% | $48 → $60 | Maintains | Overweight | Get Alert |
| 11/17/2021 | PRLD | Buy Now | Prelude Therapeutics | $0.74 | 2602.7% | Peter Lawson42% | $33 → $20 | Maintains | Overweight | Get Alert |
| 11/09/2021 | RCUS | Buy Now | Arcus Biosciences | $8.57 | 460.09% | Peter Lawson42% | $45 → $48 | Maintains | Overweight | Get Alert |
| 11/08/2021 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Peter Lawson42% | $50 → $11 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/08/2021 | PRLD | Buy Now | Prelude Therapeutics | $0.74 | 4359.46% | Peter Lawson42% | $80 → $33 | Maintains | Overweight | Get Alert |
| 08/06/2021 | ILMN | Buy Now | Illumina | $82.28 | 343.61% | Peter Lawson42% | $355 → $365 | Maintains | Underweight | Get Alert |
| 05/28/2021 | CTMX | Buy Now | CytomX Therapeutics | $0.60 | 1076.27% | Peter Lawson42% | $9 → $7 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 05/28/2021 | ADAP | Buy Now | Adaptimmune Therapeutics | $0.23 | 1628.61% | Peter Lawson42% | → $4 | Initiates | → Underweight | Get Alert |
| 05/19/2021 | IOVA | Buy Now | Iovance Biotherapeutics | $3.61 | 1008.03% | Peter Lawson42% | $60 → $40 | Maintains | Overweight | Get Alert |
| 03/12/2021 | MGNX | Buy Now | Macrogenics | $1.50 | 2566.67% | Peter Lawson42% | $14 → $40 | Upgrade | Underweight → Overweight | Get Alert |
| 02/18/2021 | BPMC | Buy Now | Blueprint Medicines | $89.60 | 6.03% | Peter Lawson42% | $90 → $95 | Maintains | Equal-Weight | Get Alert |
| 02/10/2021 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Peter Lawson42% | $85 → $70 | Maintains | Overweight | Get Alert |
| 10/22/2020 | AGIO | Buy Now | Agios Pharmaceuticals | $30.70 | 49.84% | Peter Lawson42% | → $46 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 10/06/2020 | IOVA | Buy Now | Iovance Biotherapeutics | $3.61 | 897.23% | Peter Lawson42% | $45 → $36 | Maintains | Overweight | Get Alert |
| 05/22/2020 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.75 | 67.27% | Peter Lawson42% | $25 → $23 | Maintains | Overweight | Get Alert |
| 05/05/2020 | BPMC | Buy Now | Blueprint Medicines | $89.60 | -34.15% | Peter Lawson42% | → $59 | Initiates | → Equal-Weight | Get Alert |
| 05/05/2020 | IMMU | Buy Now | Immunomedics | — | — | Peter Lawson42% | → $40 | Initiates | → Overweight | Get Alert |
| 05/05/2020 | REPL | Buy Now | Replimune Group | $10.45 | 100.96% | Peter Lawson42% | → $21 | Initiates | → Overweight | Get Alert |
| 03/04/2020 | NKTR | Buy Now | Nektar Therapeutics | $0.80 | 3654.69% | Peter Lawson42% | → $30 | Initiates | → Overweight | Get Alert |
| 03/04/2020 | EPZM | Buy Now | Epizyme | — | — | Peter Lawson42% | → $33 | Initiates | → Overweight | Get Alert |
| 03/04/2020 | XNCR | Buy Now | Xencor | $11.51 | 143.27% | Peter Lawson42% | → $28 | Initiates | → Underweight | Get Alert |
| 03/04/2020 | IOVA | Buy Now | Iovance Biotherapeutics | $3.61 | 1146.54% | Peter Lawson42% | → $45 | Initiates | → Overweight | Get Alert |
| 03/04/2020 | AGIO | Buy Now | Agios Pharmaceuticals | $30.70 | 62.87% | Peter Lawson42% | → $50 | Initiates | → Equal-Weight | Get Alert |
| 03/04/2020 | MGNX | Buy Now | Macrogenics | $1.50 | 433.33% | Peter Lawson42% | → $8 | Initiates | → Underweight | Get Alert |
| 03/04/2020 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.75 | 9.09% | Peter Lawson42% | → $15 | Initiates | → Overweight | Get Alert |
| 03/04/2020 | EXEL | Buy Now | Exelixis | $36.71 | -29.17% | Peter Lawson42% | → $26 | Initiates | → Overweight | Get Alert |
| 03/04/2020 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Peter Lawson42% | → $70 | Initiates | → Overweight | Get Alert |
| 03/04/2020 | RCUS | Buy Now | Arcus Biosciences | $8.57 | 180.05% | Peter Lawson42% | → $24 | Initiates | → Overweight | Get Alert |
| 03/04/2020 | FATE | Buy Now | Fate Therapeutics | $0.88 | 4459.44% | Peter Lawson42% | → $40 | Initiates | → Overweight | Get Alert |
| 03/04/2020 | KPTI | Buy Now | Karyopharm Therapeutics | $4.40 | 581.82% | Peter Lawson42% | → $450 | Initiates | → Overweight | Get Alert |
| 03/11/2019 | CTMX | Buy Now | CytomX Therapeutics | $0.60 | — | Peter Lawson42% | — | Initiates | → Overweight | Get Alert |
| 12/04/2018 | TSRO | Buy Now | Tesaro | — | — | Peter Lawson42% | $65 → $75 | Downgrade | Buy → Hold | Get Alert |
| 05/31/2018 | CYAD | Buy Now | Celyad Oncology | — | — | Peter Lawson42% | → $49 | Initiates | → Buy | Get Alert |
| 04/23/2018 | UMRX | Buy Now | Unum Therapeutics | — | — | Peter Lawson42% | → $21 | Initiates | → Buy | Get Alert |
| 04/09/2018 | NLNK | Buy Now | NewLink Genetics | — | — | Peter Lawson42% | $19 → $5 | Downgrade | Buy → Hold | Get Alert |
| 01/23/2018 | CRSP | Buy Now | CRISPR Therapeutics | $38.04 | 18.3% | Peter Lawson42% | $16 → $45 | Upgrade | Hold → Buy | Get Alert |
| 01/23/2018 | EDIT | Buy Now | Editas Medicine | $1.30 | 3361.54% | Peter Lawson42% | $17 → $45 | Upgrade | Hold → Buy | Get Alert |
| 01/23/2018 | JUNO | Buy Now | Juno Therapeutics | — | — | Peter Lawson42% | — | Downgrade | Buy → Hold | Get Alert |
| 07/14/2017 | AFMD | Buy Now | Affimed | $0.81 | 764.2% | Peter Lawson42% | → $70 | Initiates | → Buy | Get Alert |
| 07/14/2017 | EDIT | Buy Now | Editas Medicine | $1.30 | 1207.69% | Peter Lawson42% | → $17 | Initiates | → Hold | Get Alert |
| 07/14/2017 | CRSP | Buy Now | CRISPR Therapeutics | $38.04 | -57.94% | Peter Lawson42% | → $16 | Initiates | → Hold | Get Alert |
| 03/30/2017 | NLNK | Buy Now | NewLink Genetics | — | — | Peter Lawson42% | → $30 | Upgrade | Hold → Buy | Get Alert |
| 11/25/2016 | JUNO | Buy Now | Juno Therapeutics | — | — | Peter Lawson42% | $48 → $25 | Downgrade | Buy → Hold | Get Alert |
| 05/11/2016 | NLNK | Buy Now | NewLink Genetics | — | — | Peter Lawson42% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/01/2016 | TSRO | Buy Now | Tesaro | — | — | Peter Lawson42% | — | Initiates | → Buy | Get Alert |
| 01/29/2016 | JUNO | Buy Now | Juno Therapeutics | — | — | Peter Lawson42% | → $50 | Initiates | → Buy | Get Alert |
| 12/22/2015 | NLNK | Buy Now | NewLink Genetics | — | — | Peter Lawson42% | → $59 | Initiates | → Buy | Get Alert |
